Amgen Inc. PE Ratio
Data as of June 01, 2026
PE Ratio (TTM)
23.42
Stock Price
$336.79
EPS (TTM)
$14.38
Forward PE
14.35
How It's Calculated
23.42 = $336.79 ÷ $14.38
What This Means
Amgen Inc.'s PE ratio of 23.4 is in the moderate range, typical of established companies with steady earnings growth.
About Amgen Inc.
Amgen Inc. (AMGN) operates in the Healthcare sector, specifically in Drug Manufacturers - General. With a market capitalization of about $181.77B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $336.79, within a 52-week range of $267.83 to $391.29 (-13.9% from the high, +25.7% from the low). Beta of 0.43 indicates relatively lower volatility versus the market.
Trailing profit margin is about 21.0%, signaling a solid profit margin for its industry.
Understanding This Metric
The PE ratio is one of the most widely cited valuation multiples. For Amgen Inc., it reflects how much investors pay today for each dollar of trailing earnings. High-growth Healthcare names often carry elevated PE ratios when the market prices in faster future profits, while mature companies with stable cash flows may trade at lower multiples even in the same sector.
Sector Comparison
Among Healthcare names on our S&P 100 coverage, Amgen Inc.'s PE ratio of 23.42 can be compared with peers such as LLY (39.21), JNJ (26.11), UNH (28.66). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Healthcare stocks.
Key Takeaways
- AMGN is grouped in the Healthcare sector for peer comparisons.
- Recent beta of 0.43 suggests lower-than-market price sensitivity.
- Trailing profit margin of 21.0% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for AMGN.
PEG Ratio
2.23
Sector
Healthcare
Other AMGN Metrics
Frequently Asked Questions
What does AMGN's PE ratio mean?
The PE ratio shows how much investors pay per dollar of trailing earnings for Amgen Inc.. A trailing PE of 23.42 means the market is pricing the stock at 23.42 times last twelve months' EPS — useful for comparing valuation across time and versus Healthcare peers, not as a buy/sell signal on its own.
Is 23.42 high or low vs sector peers?
Among Healthcare names in our S&P 100 coverage, peers such as REGN (15.02), BMY (16.02), GILD (18.29) offer context. AMGN's PE of 23.42 should be read with growth, margins, and balance-sheet risk — high PE can mean strong growth expectations; low PE can mean value or weaker outlook.
How often is this PE updated?
StockCalc refreshes AMGN metrics on U.S. trading days; this page shows data as of June 01, 2026. PE moves with price daily and with EPS when companies report earnings.
Calculate the pe ratio for any stock with our free calculator.
Open PE Ratio Calculator →